Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
Integrated Research Ltd > ABN 76 003 588 449
Level 9, 100 Pacific Highway, North Sydney NSW 2060 Australia
t: +61 (2) 9966 1066 e: InfoAP@ir.com
17 October 2023
ASX Market Announcements Office
Australian Securities Exchange
Dear Shareholder,
ASX Market Announcement
Annual General Meeting 2023
In accordance with the ASX Listing Rules, Integrated Research Limited (ASX: IRI) encloses for release
to the market:
•
Notice of the 2023 Annual General Meeting
•
Proxy Form
•
Shareholder Question Form
To be followed by
•
2023 Annual Report
By authority of the Board
Will Witherow
Company Secretary
Integrated Research Limited
ABN 76 003 588 449
1
www.ir.com
Notice of Annual General Meeting
Integrated Research Limited
ABN: 76 003 588 449
Notice is given that the 2023 Annual General Meeting (the AGM or Meeting) of Integrated Research Limited (the
Company) will be a hybrid meeting, where Shareholders may attend in person at The Museum of Sydney, corner of
Phillip Street and Bridge Street or online at https://meetnow.global/MTGZ6MX on Wednesday 22 November 2023 at
10:00am (AEDT).
Shareholders are invited to participate in the AGM in person, virtually via our online AGM platform or via the
appointment of a proxy. Further information on how Shareholders and their representatives can participate in the AGM is
set out in this notice of meeting.
ITEMS OF BUSINESS
Ordinary Business
1.
Consideration of Financial Report and Directors’ and Auditor’s Reports
To receive and consider the Financial Report, Directors' Report, and Independent Auditor's Report for the year ended
30 June 2023.
2.
Remuneration Report
To consider, and if thought fit, pass the following resolution as an advisory ordinary resolution:
“That the Remuneration Report of the Company for the financial year ended 30 June 2023, forming part of the 2023
Annual Report, be adopted.”
Note: Pursuant to section 250R(3) of the Corporations Act 2001 (Cth) (Corporations Act), the vote on this resolution
is advisory only and does not bind the Directors or the Company. However, the Directors will take into consideration
the outcome of the Shareholders’ vote on this matter in determining future remuneration policy for Directors and
executives of the Company.
3.
Re-election of James Scott
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
“That James Scott, a Director retiring in accordance with Rule 6.1(f) of the Company’s constitution and, being
eligible, be re-elected as a Non-Executive Director of the Company.”
4.
Election of Mark Brayan
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
"That Mark Brayan be elected as a Non-Executive Director of the Company."
5.
Election of Michael Hitz
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
"That Michael Hitz be elected as a Non-Executive Director of the Company."
Special Business
6.
Issue of Performance Rights to John Ruthven
To consider, and if thought fit, to pass the following resolution as an ordinary resolution:
“That for the purposes of ASX Listing Rule 10.14 and for all other purposes, approval is given for the Company to
grant up to 897,436 performance rights in the Company (“Performance Rights”) to its Managing Director and Chief
Executive Officer, John Ruthven, and the acquisition of up to 897,436 ordinary shares in the Company by John
Ruthven on exercise of the Performance Rights, in accordance with the Integrated Research Rights & Option Plan
and on the terms set out in the Explanatory Notes accompanying this Notice of Meeting”.
1.
By order of the Board
Will Witherow
Company Secretary
17 October 2023
2.
How to participate in the AGM
The Company's AGM will be held as a hybrid meeting where Shareholders may attend in person, via proxy or via an online
platform.
There are a number of ways to participate in the AGM :
•
In person or via proxy: at The Museum of Sydney, corner of Phillip Street and Bridge Street, Sydney NSW 2000 on
Wednesday 22 November 2023; and
•
online: Shareholders and proxyholders may participate in the AGM online, which will allow them to view a live
webcast, ask questions and vote.
How to participate online
To participate in the Meeting, Shareholders can log in by entering the https://meetnow.global/MTGZ6MX on your
computer, tablet or smartphone (Online AGM Portal).
You will require your Shareholder Reference Number (SRN), Holding Identification Number (HIN), registered postcode
and country code for the registration process.
Proxyholders will need to contact the Company's registry, Computershare (+61 3 9415 4024), prior to the Meeting to
obtain login details. Registration for the Meeting will open one hour before the AGM, from 9:00am (AEDT) on
Wednesday 22 November 2023.
To participate in the Meeting online follow the instructions below.
1.
Click 'Join Meeting Now'.
2.
Enter your SRN / HIN.
Proxyholders will need to contact Computershare to obtain login details.
3.
Australian securityholder: enter the postcode registered to your holding.
Overseas securityholder: select the country of your registered holding from the drop-down
list.
4.
Accept the Terms and Conditions, and click 'Continue'.
Registration for the AGM will open from 9:00am (AEDT) on Wednesday 22 November 2023.
For further information, refer to the Online AGM User Guide which can be found on the Company's registry website at
www.computershare.com.au/virtualmeetingguide .
Please note that only Shareholders or their appointed representatives may vote or ask questions during the AGM. It may not
be possible to respond to every question raised during the AGM. Shareholders are encouraged to lodge questions prior to
the AGM, via the Shareholder Question Form enclosed with this notice of meeting or online.
Poll
Each resolution will be decided by a poll.
Voting entitlements
For the purpose of the AGM, the Directors have determined that shares in the Company will be taken to be held by
persons registered as Shareholders as at 7:00pm (AEDT) on Monday 20 November 2023.
Shareholders and their appointed representatives that are entitled to vote at the AGM may vote during the AGM in person
or via the Online AGM Portal.
3.
Voting exclusion statement – Item 2
In accordance with section 250R(4) of the Corporations Act, a vote must not be cast on the resolution in Item 2 in any
capacity by or on behalf of:
a)
a member of the Company's Key Management Personnel (including directors) (KMP), whose remuneration
details are included in the Remuneration Report for the financial year ended 30 June 2023; or
b) their closely related parties; or
c) as proxy by a person who is a member of the KMP of the Company and their closely related parties.
A “closely related party” of a member of the KMP of the Company means a spouse or child of the member, a child of the
member’s spouse, a dependant of the member or the member’s spouse, anyone else who is one of the member’s family
and may be expected to influence the member, or be influenced by the member, in the member’s dealings with the
Company, or a company the member controls.
However, a vote may be cast on the resolution in Item 2 by such persons where it is cast as proxy for a person entitled to
vote on the resolution in Item 2, and:
a) the proxy appointment is in writing and specifies how the proxy is to vote on the resolution in Item 2; or
b) the proxy is the chair of the meeting, and:
(i) the appointment does not specify the way the proxy is to vote on the resolution; and
(ii) the appointment expressly authorises the chair to exercise the proxy even if the resolution is connected
directly or indirectly with the remuneration of the Company’s KMP.
If you appoint the Chair of the AGM as your proxy, and you do not direct your proxy how to vote on the resolution in
Item 2 on the Proxy Form, you will be expressly authorising the Chair of the AGM to exercise your proxy even if the
resolution in Item 2 is connected directly or indirectly with the remuneration of a member of the Company’s KMP. The
Chair is a member of the KMP.
Voting exclusion statement – Item 6
In accordance with the ASX Listing Rules, the Company will disregard any votes cast in favour of the resolution in Item
6 by or on behalf of Mr John Ruthven, the Company's Managing Director and Chief Executive Officer, or any of his
associates. However, the Company will not disregard a vote if it is cast by:
a)
a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote in that way; or
b) the Chair of the meeting as a proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the Chair to vote as the Chair decides; or
c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an associate of a person excluded from voting, on the resolution, and
(ii) the holder votes on the resolution in accordance with the directions given by the beneficiary to the
holder to vote in that way.
Mr Ruthven is the only Director currently eligible to participate in an employee incentive scheme of the Company.
In addition, as the resolution in Item 6 is directly related to the remuneration of a member of the Company's KMP (i.e.,
Mr Ruthven) , a vote must not be cast on the resolution in Item 6 by a member of the Company's KMP, or a KMP’s
closely related party, as a proxy, unless the vote is cast:
a)
b)
for a person entitled to vote in accordance with the directions on the Proxy Form; or
by the Chair of the AGM for a person entitled to vote and the Chair has received express authority to vote
undirected proxies as the Chair sees fit on the resolution in Item 6 even though that resolution is connected
directly or indirectly with the remuneration of a member of the KMP of the Company.
4.
If you appoint the Chair of the AGM as your proxy, and you do not direct your proxy how to vote on the resolution in
Item 6 on the Proxy Form, you will be expressly authorising the Chair of the AGM to exercise your proxy even if the
resolution in Item 6 is connected directly or indirectly with the remuneration of a member of the KMP. The Chair is a
member of the KMP.
The Chair of the AGM intends to vote undirected proxies able to be voted in favour of Item 1 to 6. Accordingly, if you
appoint the Chair of the AGM as your proxy and wish for the Chair to vote differently to how the Chair of the AGM
intends to vote on any of the resolutions, you will need to direct your proxy how to vote by marking the appropriate box
(“For”, “Against” or “Abstain”) on the Proxy Form for the relevant item.
Proxies
A Shareholder has the right to appoint a proxy, who need not be a shareholder of the Company. If a Shareholder is
entitled to two or more votes they may appoint two proxies and may specify the percentage or number of votes each
proxy is appointed to exercise. If a Shareholder appoints two proxies and the appointment does not specify the proportion
or number of votes each proxy may exercise, each proxy may exercise half of the Shareholder’s votes (disregarding any
fractions of votes). Proxy Forms (and any Power of Attorney under which it is signed) must be received at any given
address below or lodged online no later than 10:00am (AEDT) on Monday 20 November 2023. Proxy Forms received
after that time will not be effective.
The Proxy Form must be signed by the Shareholder or the Shareholder’s attorney. Proxies given by corporations must be
executed in accordance with the Corporations Act. Where the appointment of a proxy is signed by the appointor’s
attorney, a certified copy of the power of attorney must be received at any given address below or online no later than
10:00am (AEDT) on Monday 20 November 2023.
The Proxy Form must be completed and returned by:
•
•
•
mail to the share registry of the Company, Computershare Investor Services Pty Limited, at GPO Box 242
Melbourne, Victoria 3001, Australia
mail or hand delivered to the Company at its registered office at Level 9, 100 Pacific Highway, North Sydney,
NSW 2060; or
facsimile to Computershare on 1800 783 447 within Australia or +61 3 9473 2555 from overseas.
You can also lodge your Proxy Form online by visiting www.investorvote.com.au or scanning the QR Code with your
mobile device. Follow the instructions on the secure website to vote.
Privacy
Chapter 2C of the Corporations Act requires information about you (including your name, address and details of the
shares you hold) to be included in the Company's public register of members. This information must continue to be
included in the public register if you cease to hold shares. These statutory obligations are not altered by the Privacy
Amendment (Private Sector) Act 2000 (Cth). Information is collected to administer your shareholding which may not be
possible if some or all of the information is not collected. Your information is collected by Computershare on behalf of
the Company. Computershare's privacy policy is available at www.computershare.com.au.
The Explanatory Notes and the Proxy Form are enclosed and form part of this notice of meeting.
By order of the Board
Will Witherow
Company Secretary
5.
Explanatory Notes
The following notes explain the items of business to be considered at the AGM and form part of, and should be read in
conjunction with, the Notice of Meeting.
Item 1: Financial report and directors’ and auditor’s reports
As required by the Corporations Act, the Financial Report of the Company, Directors' Report and Auditor's Report for the
financial year ended 30 June 2023 will be laid before the AGM.
No vote is required to be cast in relation to this item. It is intended to provide an opportunity for Shareholders as a whole
to raise questions on the reports themselves and on the performance and management of the Company.
The Auditors of the Company will be present at the AGM and Shareholders will be given a reasonable opportunity to ask
the Auditors questions about the content and preparation of the Auditor’s Report, the conduct of the audit, the accounting
policies adopted by the Company in relation to the preparation of the financial statements and the independence of the
auditor in relation to the conduct of the audit.
Item 2: Remuneration Report
In accordance with section 250R of the Corporations Act, the Company must put to Shareholders a resolution that the
Remuneration Report for the financial year ended 30 June 2023 be adopted. The full Remuneration Report is contained in
the Company’s 2023 Annual Report.
The vote on this resolution is advisory only and does not bind the Company or the Directors. However, the Directors will
take into consideration the outcome of the Shareholders’ vote on this matter in determining future remuneration policies
for Directors and Executives of the Company.
The Chair will allow Shareholders a reasonable opportunity, as a whole, to ask questions about, or make comments on,
the Remuneration Report, following which the advisory resolution will be put to members.
The Directors consider that the Company’s remuneration levels, including the grant of short and long-term incentive
arrangements, are competitively set to attract and retain appropriately qualified and experienced Directors and Senior
Executives and are consistent with other successful mid-size listed companies in the technology sector in Australia. The
Company's approach to remuneration also ensures that the interests of Directors and Senior Executives for the short,
medium and long term are aligned with the interests of Shareholders.
Recommendation: Acknowledging that each Director has a personal interest in his / her own remuneration from the
Company as described in the Remuneration Report, the Directors recommend that Shareholders vote in favour of the
resolution in Item 2.
6.
Item 3: Re-election of James Scott
James was appointed a Director in May 2021. He is a seasoned professional with over 26 years’ experience in the media
and technology sector, with industry and advisory businesses at a local and international level. Mr. Scott is currently an
operational advisor to private equity firm, Liverpool Partners; a non-executive Director of Boom Logistics (ASX:BOL);
non-executive Director of Orbx Pty Ltd; Chair of MerchantWise Group Pty Ltd; Chair of Seisma Pty Ltd; Chair of
Simplyai Pty Ltd; and was previously non-executive Chair of Skyfii (ASX:SKF). James was previously Managing Director
of Accenture Digital; a Partner in KPMG’s Advisory division; and was the Chief Operating Officer of Seven Group
Holdings (ASX:SVW). Mr. Scott was a founder and Director of Imagine Broadband Limited; and was a Director of
WesTrac and Coates Hire during his time with Seven Group Holdings.
Recommendation: Directors (excluding James Scott) recommend that Shareholders vote in favour of the resolution in Item
3.
Item 4: Election of Mark Brayan
Mark Brayan is a seasoned Chief Executive Officer. He has run five Australian technology companies in various domains
including communications and artificial intelligence. He is an experienced Managing Director of public and private
companies. Mark is currently CEO of Soprano, a privately held global leader in the Communication Platform As A Service
(CPaaS) market.
Prior to Soprano, Mark was CEO and Managing Director of Appen from 2015 to 2023. Appen is listed on the ASX and is a
global provider of AI data and services. Before Appen, Mark was CEO and Managing Director of MineSite Technologies,
a privately held business that provided communication technologies to heavy and hazardous industries. He was CEO and
Managing Director of Integrated Research Limited, from 2007 to 2013.
Mark has a Masters of Business Administration (MBA) from the Australian Graduate School of Management (AGSM) and
a First Class Honours Bachelor of Surveying from the University of New South Wales.
Recommendation: Directors provide no voting recommendation for the resolution in Item 4.
Item 5: Election of Michael Hitz
Michael's career spans roles from engineering communications infrastructure in energy, mining and telecommunications, to
corporate strategy, mergers and acquisitions and investing. Over the past five years Michael has worked with a leading panAsian fund to invest in public companies pursuing growth in payments, telecommunications and energy. Prior to this, Michael
was a Partner and Managing Director for The Boston Consulting Group, where he held roles including leading the technology,
media and telecommunications business.
Michael is a Director of The Institute for Economics and Peace Limited. Michael holds a degree in computer engineering
with honours from the University of Newcastle, Australia.
Recommendation: Directors recommend that Shareholders vote in favour of the resolution in Item 5.
7.
Item 6: Issue of Performance Rights to John Ruthven
John Ruthven was appointed by the Company to the position of Chief Executive Officer (CEO) with effect from 8 July
2019 and was subsequently appointed as Managing Director from 12 September 2019.
ASX Listing Rule 10.14 requires shareholder approval for the acquisition of equity securities by a Director under an
employee incentive scheme. As part of the Company’s remuneration strategy and approach to long-term incentives
(LTIs), Item 6 requests Shareholders to approve the grant of up to 897,436 Performance Rights to the CEO and
Managing Director, John Ruthven, under the Integrated Research Limited Equity Plan Rules (Equity Plan), as part of his
FY24 remuneration package.
The number of Performance Rights for which approval is being sought has been determined by dividing the face value of
the CEO’s LTI opportunity for FY24, being AUD350,000, by the Company’s 10-day closing price volume weighted
average share price (VWAP) on 7 September 2023. The 10-day closing price VWAP on that date was AUD0.39.
Performance Rights have been proposed as the LTI as it provides immediate share price exposure. The actual value (if
any) that Mr. Ruthven will receive from the Performance Rights will depend on the extent to which the performance
hurdles are achieved.
The Equity Plan is a key component of the Company's compensation arrangement for the CEO. Mr. Ruthven’s total
remuneration package for FY24 includes total fixed remuneration, short term incentive and the grant of Performance
Rights under the Equity Plan. The Board considers that the value of Mr Ruthven’s remuneration package, including the
grant of Performance Rights, is within market range for an experienced CEO of a mid-size listed company in the
technology sector in Australia. The grant of Performance Rights under the Equity Plan, and the fact that Performance
Rights are subject to the Company achieving agreed hurdles, allows the Company to:
•
•
•
ensure that the CEO's medium and long-term interests are aligned with the interests of Shareholders of the
Company;
match rewards under the CEO’s remuneration with the long-term performance of the Company; and
provide the CEO with a remuneration opportunity consistent with market standards to retain suitable
candidates for the CEO position.
The CEO is the only Director of the Company entitled to participate in the Equity Plan.
The Performance Rights to be granted to the CEO in FY24 will vest in three tranches subject to satisfaction of both the
performance and service conditions on the applicable vesting date. The Board determined the use of Performance Rights
aligns with Shareholder expectations and should be granted to the CEO (subject to Shareholder approval being obtained).
The Company’s share price during the performance period will normally determine whether the Performance Rights are
exercised on the vesting date. At the time any Performance Rights are exercised, and shares are issued pursuant thereto,
the Company’s shares may be trading at a higher price than the exercise price of the Performance Rights. The
Performance Rights will not be quoted on the ASX and as such have no actual market value on the date of grant. The
fully paid ordinary shares of the Company have traded on the ASX since December 2000. During the twelve month
period prior to the date of this notice, shares have traded in the range of $0.317 to $0.67. The most recent closing price
prior to the date of this notice was $0.34.
Accordingly, the Performance Rights to be granted to the CEO for FY24 are subject to the sole performance measure of
share price improvement over a three-year performance period, vesting in three equal tranches.
For each tranche of Performance Rights, the performance condition will only be met if the Company’s share price reaches
the target value of VWAP for the ten trading days following the release of the Company’s full year Financial Report for
the year a tranche becomes available for vesting.
Summary of the Performance Rights allocation terms
The key commercial terms of the Performance Rights proposed to be granted to Mr Ruthven under the Equity Plan are
summarised below.
8.
Terms and Conditions
Number of Performance Rights:
Exercise Condition:
Service Conditions:
Performance Condition
Tranche 1:
Subject to Shareholder approval, 897,436 Performance Rights will be granted
under the Equity Plan in two tranches of 299,145 and one tranche of 299,146.
Each Performance Right, subject to the satisfaction of Exercise Conditions,
entitles the CEO to receive one fully paid ordinary share in the Company on
payment of the Exercise Price (if any). The Board has determined that no
Exercise Price is payable in relation to these Performance Rights.
The ability of the Performance Rights to automatically vest and exercise is
dependent upon the CEO meeting both the Performance Condition and
Service Condition for each tranche on the applicable Vesting Date.
Vesting of Performance Rights on an applicable Vesting Date is subject to the
following conditions being satisfied:
(a) the CEO continues to be continuously employed by the Company
throughout the period and on the applicable Vesting Date (unless
terminated due to death, disability, or redundancy); and
(b) during the course of the period until the Vesting Date, the CEO
(i) acts in good faith and fully co-operates in the strategic initiatives of
the Company, and
(ii) complies with and follows the directions of the Board, Board
Committees or Board Sub-Committees (or any member of such
Committee/s or the Board).
If any of the Service Conditions are not satisfied, the Performance Rights will
lapse immediately.
In respect of Tranche 1 consisting of 299,145 Performance Rights:
(i) Vesting in 2024: Where the Company’s share price, calculated using the
closing share price VWAP of the Company for the ten (10) trading days
following the release of the Company’s FY24 Financial Report, is equal
to or greater than AUD0.80, the percentage of Tranche 1 Performance
Rights that will vest against the Performance Condition is 100%.
(ii) Nil Vesting in 2024: Where the Company’s share price, calculated using
the closing share price VWAP of the Company for the ten (10) trading
days following the release of the Company’s FY24 Financial Report, is
less than AUD0.80, the percentage of Tranche 1 Performance Rights
that will vest against the Performance Condition is Nil.
Performance Condition
Tranche 2:
Tranche 1 Performance Rights which do not meet the Performance Condition
of AUD0.80 may be carried forward for retesting against (i) the Tranche 2
Performance Condition of AUD1.20 (ii) the Tranche 3 Performance
Condition of AUD1.60. There is no retesting of Performance Rights after the
Vesting Date.
In respect of Tranche 2 consisting of 299,145 Performance Rights:
(i) Vesting in 2025: Where the Company’s share price, calculated using the
closing share price VWAP of the Company for the ten (10) trading days
following the release of the Company’s FY25 Financial Report, is equal
to or greater than AUD1.20, the percentage of Tranche 2 Performance
Rights that will vest against the Performance Condition is 100%.
(ii) Nil Vesting in 2025: Where the Company’s share price, calculated using
the closing share price VWAP of the Company for the ten (10) trading
days following the release of the Company’s FY25 Financial Report is
less than AUD1.20, the percentage of Tranche 2 Performance Rights
that will vest against the Performance Condition is Nil.
9.
Terms and Conditions
Performance Condition
Tranche 3:
Tranche 2 Performance Rights which do not meet the Performance Condition
of AUD1.20 may be carried forward for retesting against the Tranche 3
Performance Condition of AUD1.60. There is no retesting of Performance
Rights after the Vesting Date.
In respect of Tranche 3 consisting of 299,146 Performance Rights:
(i) Full vesting in 2026: Where the Company’s share price, calculated using
the closing share price VWAP of the Company for the ten (10) trading
days following the release of the Company’s FY26 Financial Report, is
equal to or greater than AUD1.60, the percentage of Tranche 2
Performance Rights that will vest against the Performance Condition is
100%.
(ii) Nil Vesting in 2026: Where the Company’s share price, calculated using
the closing share price VWAP of the Company for the ten (10) trading
days following the release of the Company’s FY26 Financial Report, is
less than AUD1.60, the percentage of Tranche 3 Performance Rights
that will vest against the Performance Condition is Nil.
Vesting Date
Delivery of Shares:
Change of control
Malus and clawback
Tranche 3 Performance Rights which do not meet the Performance Condition
of AUD1.60 will lapse. Similarly, any Tranche 1 or Tranche 2 Performance
Rights which have been carried forward for retesting against the Tranche 3
Performance Condition of AUD1.60 will also lapse. There is no retesting of
Performance Rights after the Vesting Date.
The Vesting Dates are:
• for the Tranche 1 Performance Rights, ten (10) trading days following
the release of the Company’s FY24 Financial Report;
• for the Tranche 2 Performance Rights, ten (10) trading days following
the release of the Company’s FY25 Financial Report; and
• for the Tranche 3 Performance Rights, ten (10) trading days following
the release of the Company’s FY26 Financial Report.
Any Performance Rights which are not exercised by the Vesting Date will
automatically lapse.
The Company must either issue the relevant number of fully paid ordinary
shares in the Company, or procure the transfer of the relevant number of
shares (e.g. by acquiring them on-market), on the exercise of Performance
Rights within 30 days of the relevant Vesting Date.
In the event of a takeover or other change of control, any unvested
Performance Rights will vest at the discretion of the Board.
The awards will be subject to malus considerations by the Board and in
relation to serious and material matters may be subject to a reduction or
adjustment prior to exercise or clawback. In the event of fraud, dishonesty or
breach of obligations (including legal and statutory non-compliance), the
Board may take any actions to ensure that no unfair benefit is obtained.
10.
CEO’s FY24 Remuneration
ASX Listing Rule 10.14 requires the Company to seek approval from its Shareholders before issuing any securities to any
Director of the Company or their associates under an employee incentive scheme.
Approval of the resolution in Item 6 will also result in the Performance Rights granted to the CEO being included as an
exception to the approval requirements of ASX Listing Rule 7.1. This means the Performance Rights granted to the CEO,
and any other shares issued pursuant to this approval, will not use up part of the placement capacity available to the
Company under ASX Listing Rule 7.1.
In
Share your feedback
Discover